Abivax SA (ABVX)
NASDAQ: ABVX · IEX Real-Time Price · USD
13.35
+0.15 (1.14%)
At close: Jul 11, 2024, 4:30 PM
13.36
+0.01 (0.07%)
Pre-market: Jul 12, 2024, 7:09 AM EDT

Abivax Revenue

In the year 2023, Abivax had annual revenue of $5.13M with 5.31% growth.

Revenue (ttm)
$5.13M
Revenue Growth
+5.31%
P/S Ratio
163.59
Revenue / Employee
$84,171
Employees
61
Market Cap
839.95M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.13M258.91K5.31%
Dec 31, 20224.88M-8.72M-64.13%
Dec 31, 202113.59M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.